Eight Roads Ventures, F-Prime Capital completed the acquisition of a 8% stake in Enzene Biosciences for $20m.

Synopsis

Private equity firms Eight Roads Ventures, F-Prime Capital completed the acquisition of a 8% stake in Enzene Biosciences, a biotechnology company, for $20m.

Principals

target

Enzene Biosciences

bidder

F-prime Capital

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (3)

himanshu gadgil

CEO at ENZENE BIOSCIENCES LTD

Manager

target

Deal

£ 16 M

Total Value

nagavalli gopalakrishna

Partner at Cyril Amarchand Mangaldas

Lawyer

target

Deals

£ 1.16 B

Total Value

ayushi mishra

Senior Associate at Cyril Amarchand Mangaldas

Lawyer

target

Deals

£ 987 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy